Skip to content

Evaluation of Clinical Decision Support System for Intracranial Hemorrhage Using Brain CT Images

An Open Label, Single-Center and Random-Selection Retrospective Pivotal Study of Clinical Decision Support System for Intracranial Hemorrhage Using Brain CT Images

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04983953
Enrollment
236
Registered
2021-07-30
Start date
2021-06-23
Completion date
2021-07-28
Last updated
2022-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracranial Hemorrhages

Brief summary

cHS is a software that has been pre-learned based on a intracranial haemorrhage diagnosis model using brain CT images, and clinical decision support system for diagnosing intracranial haemorrhage by automatically analyzing brain CT images by assisting the medical team. The specific aims of this study are to evaluate efficacy of cHS for intracranial haemorrhage compared to the sensitivity and specificity levels of predicate device which is currently approved to triage intracranial haemorrhage.

Interventions

DEVICEcHS

Clinical decision support system for diagnosing intracranial haemorrhage

Sponsors

Heuron Inc.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults over 19 years old * Brain CT acquired * Abnormal cohort: A patient diagnosed with intracranial haemorrhage after a brain CT scan * Normal cohort: A normal person or a patient not diagnosed with intracranial haemorrhage after a brain CT scan

Exclusion criteria

* Patients with brain tumor or cerebral toxoplasmosis * Patients with brain abscess or brain calcification * Poor or incomplete brain CT image quality

Design outcomes

Primary

MeasureTime frameDescription
Sensitivity and specificity of cHSWithin 4 weeks after collecting dataSensitivity and specificity of cHS in diagnosis of intracranial haemorrhage based on golden standards

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026